Online Information for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research study is to understand the perspectives of U.S. adults on online information about prostate cancer. Study participants will receive different online information about prostate cancer to view such as a video post or text post, and complete a one-time online survey that will take approximately 10 minutes.
Who Is on the Research Team?
Stacy Loeb, MD, MSc, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This study is for U.S. adults age 40 or older who identify as Black and/or Hispanic, are part of the Dynata online survey panel, and are willing to take part in a research survey.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive different online information about prostate cancer and complete a one-time online survey
Follow-up
Participants are monitored for immediate responses to the online information
What Are the Treatments Tested in This Trial?
Trial Overview
Participants will view either a text or video post about prostate cancer online and then complete a one-time, 10-minute online survey to share their opinions on the information presented.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will receive a survey and be asked their perspective after reviewing a prostate cancer post without video.
Participants will receive a survey and be asked their perspective after reviewing a prostate cancer post with video
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.